The board of directors of Everest Medicines Limited announced that Ms. Yin Yin (Ms. Yin) has tendered her resignation as a joint company secretary of the company with effect from January 31, 2022 due to personal reason.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.95 HKD | +1.86% | -3.30% | +5.02% |
05-14 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
05-14 | Everest Medicines Announces Commercial Launch and First Prescription for NEFECON in Mainland China | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.02% | 883M | |
-0.67% | 90.85B | |
-0.92% | 39.02B | |
-9.57% | 33.46B | |
-17.98% | 14.51B | |
-6.74% | 13.22B | |
-9.76% | 11.65B | |
-47.31% | 10.57B | |
+6.52% | 9.23B | |
+137.06% | 7.71B |
- Stock Market
- Equities
- 1952 Stock
- News Everest Medicines Limited
- Everest Medicines Limited Announces Resignation of Ms. Yin Yin as Joint Company Secretary